Randomised controlled trial of the short term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder
Latest Information Update: 28 Oct 2022
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms CIAO-II
- 13 Jul 2019 Status changed from active, no longer recruiting to completed.
- 24 Jun 2016 New trial record
- 16 Jun 2016 Status changed from recruiting to active, no longer recruiting.